These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1499363)

  • 1. Cardiovascular consequences of obesity.
    Dustan HP
    Chin Med J (Engl); 1992 May; 105(5):360-3. PubMed ID: 1499363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and cardiovascular disease.
    Shaper AG
    Ciba Found Symp; 1996; 201():90-103; discussion 103-7, 188-93. PubMed ID: 9017276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obesity epidemic: pathophysiology and consequences of obesity.
    Pi-Sunyer FX
    Obes Res; 2002 Dec; 10 Suppl 2():97S-104S. PubMed ID: 12490658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and cardiovascular risk: the new public health problem of worldwide proportions.
    Scaglione R; Argano C; Di Chiara T; Licata G
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):203-12. PubMed ID: 15151469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Obesity and cardiovascular morbidity].
    Berg A; Bönner G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
    Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):968-76. PubMed ID: 16627822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of sustained moderate weight loss in obesity.
    Pasanisi F; Contaldo F; de Simone G; Mancini M
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and health complications of obesity.
    Grundy SM; Barnett JP
    Dis Mon; 1990 Dec; 36(12):641-731. PubMed ID: 2261844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.
    Onat A; Sari I; Hergenç G; Yazici M; Uyarel H; Can G; Sansoy V
    Metabolism; 2007 Mar; 56(3):348-56. PubMed ID: 17292723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity in children and hypertension].
    Di Salvo G; Pacileo G; del Giudice EM; Rea A; Natale F; Castaldi B; Gala S; Fratta F; Limongelli G; Calabrò P; Perrone L; Calabrò R
    G Ital Cardiol (Rome); 2008 Jun; 9(6):394-401. PubMed ID: 18681390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Leiter LA; Abbott D; Campbell NR; Mendelson R; Ogilvie RI; Chockalingam A
    CMAJ; 1999 May; 160(9 Suppl):S7-12. PubMed ID: 10333848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A survey of obesity and cardiovascular disease].
    Yao CL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1986 Oct; 7(5):277-9. PubMed ID: 3779825
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoproteins abnormalities in obese insulin-resistant dogs.
    Bailhache E; Nguyen P; Krempf M; Siliart B; Magot T; Ouguerram K
    Metabolism; 2003 May; 52(5):559-64. PubMed ID: 12759884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum lipids during starvation in obesity.
    Balázsi I; Karádi I; Somogyi A; Jóna G; Romics L
    Acta Med Hung; 1983; 40(2-3):133-8. PubMed ID: 6669442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Health risks and economic costs associated with obesity requiring a comprehensive weight reduction program].
    Hainer V; Kunesová M; Parízková J; Stunkard A
    Cas Lek Cesk; 1997 Jun; 136(12):367-72. PubMed ID: 9333508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.